These data would appear to link NRF2 activation, intrarenal RAS and SGLT2 expression and tubular lipid accumulation, to the exacerbation of hypertension, dysglycemia, and kidney injury in T2D. The gene discussed is SLC5A2; the disease is Hypertension.